Related Experiment Video
Updated: Oct 6, 2025

Spontaneous and Evoked Measures of Pain in Murine Models of Monoarticular Knee Pain
Published on: February 22, 2019
Proteomics based markers of clinical pain severity in juvenile idiopathic arthritis
Hanne Van Der Heijden1,2,3, Benoit Fatou4, Diana Sibai1
1Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Insights
This pilot study explored serum proteomes in children with juvenile idiopathic arthritis (JIA) to understand pain mechanisms. Key proteins linked to pain severity and inflammation were identified, suggesting both inflammatory and non-inflammatory drivers of JIA pain.
Area of Science:
- Proteomics
- Rheumatology
- Pediatric Autoimmune Diseases
Background:
- Juvenile idiopathic arthritis (JIA) is a group of autoimmune rheumatic diseases affecting children.
- The molecular mechanisms underlying pain in JIA remain largely unclear.
- This study investigated serum proteome variability in relation to pain severity in JIA patients.
Purpose of the Study:
- To explore the serum proteome in JIA patients.
- To identify proteins associated with pain severity in JIA.
- To investigate correlations between pain-associated proteins, inflammation markers, and CNS morphology.
Main Methods:
- Serum samples from 15 JIA patients were analyzed using liquid chromatography/mass spectrometry (LC/MS).
- Correlation analyses assessed relationships between protein levels and self-reported pain severity.
- Associations with Erythrocyte Sedimentation Rate (ESR), subcortical volume, and cortical thickness were evaluated.
Main Results:
- 306 proteins were identified in the JIA cohort.
- 14 proteins showed a significant association with clinical pain severity (p < 0.05).
- Pain-associated proteins were linked to humoral immunity, inflammatory response, angiogenesis, ESR, and CNS morphology.
Conclusions:
- Proteomic findings suggest both inflammatory and non-inflammatory mechanisms contribute to JIA pain.
- Preliminary observations indicate potential novel serologic markers for JIA pain.
- Further validation in larger cohorts and longitudinal studies is recommended.
Introduction:
Juvenile idiopathic arthritis (JIA) is a cluster of autoimmune rheumatic diseases occurring in children 16 years of age or less. While it is well-known that pain may be experienced during inflammatory and non-inflammatory states, much remains ambiguous regarding the molecular mechanisms that may drive JIA pain. Thus, in this pilot study, we explored the variability of the serum proteomes in relation to pain severity in a cohort of JIA patients.
Methods:
Serum samples from 15 JIA patients (male and female, 12.7 ± 2.8 years of age) were assessed using liquid chromatography/mass spectrometry (LC/MS). Correlation analyses were performed to determine the relationships among protein levels and self-reported clinical pain severity. Additionally, how the expression of pain-associated proteins related to markers of inflammation (Erythrocyte Sedimentation Rate (ESR)) or morphological properties of the central nervous system (subcortical volume and cortical thickness) implicated in JIA were also evaluated.
Results:
306 proteins were identified in the JIA cohort of which 14 were significantly (p < 0.05) associated with clinical pain severity. Functional properties of the identified pain-associated proteins included but were not limited to humoral immunity (IGLV3.9), inflammatory response (PRG4) and angiogenesis (ANG). Associations among pain-associated proteins and ESR (IGHV3.9, PRG4, CST3, VWF, ALB), as well as caudate nucleus volume (BTD, AGT, IGHV3.74) and insular cortex thickness (BTD, LGALS3BP) were also observed.
Conclusions:
The current proteomic findings suggest both inflammatory- and non-inflammatory mediated mechanisms as potential factors associated with JIA pain. Validation of these preliminary observations using larger patient cohorts and a longitudinal study design may further point to novel serologic markers of pain in JIA.
Related Concept Videos
Analgesia and Pain Management
The JAK-STAT Signaling Pathway

